Research advances in the roles of lipoxin in acute lung injury and its mechanisms
Online published: 2016-07-25
Supported by
National Natural Science Foundation of China, 81272147
Acute lung injury (ALI) and its severe phase, i.e. acute respiratory distress syndrome (ARDS), is a common critical disease characterized by noncardiac pulmonary edema and refractory hypoxemia with high mortality, which seriously threatens patients’ lives. As a potent endogenous counter-regulatory lipid mediator, lipoxin (LX) plays a key role in the pathogenesis of many diseases such as ALI/ARDS and becomes a research focus in recent years. This paper reviews research advances in the roles of LX in ALI/ARDS and its mechanisms.
ZHANG Rong , ZHANG Yi-wei , WANG Yan , QI Ai-hua , WANG Li , WANG Ai-zhong . Research advances in the roles of lipoxin in acute lung injury and its mechanisms[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2016 , 36(6) : 926 . DOI: 10.3969/j.issn.1674-8115.2016.06.028
/
〈 |
|
〉 |